In Khokhar et al.’s (53) study, they showed MMP9 and PTEN to be the miR-21-5p targets in-silico analysis and suggested that metformin regulates MMP9 expression in T2DM and DN patient populations through hsa-miR-21-5p. This evidence concerns the gene MMP9 and type 2 diabetes mellitus.